Label-free single nanoparticle identification and characterization including infectious emergent virus
Minh-Chau Nguyen (XLIM), Peter Bonnaud (XLIM), Rayane Dibsy (IRIM),, Guillaume Maucort (LP2N), S\'ebastien Lyonnais (CEMIPAI), Delphine Muriaux, (IRIM, CEMIPAI), Pierre Bon (XLIM)

TL;DR
RYMINI is a novel, noninvasive optical technique that enables label-free identification and detailed characterization of individual nanoparticles, including viruses, in solution without prior knowledge or modifications.
Contribution
The paper introduces RYMINI, a compact optical system combining holographic 3D tracking and phase imaging for label-free nano-object analysis in complex environments.
Findings
Successfully characterized HIV-1, SARS-CoV-2, and vesicles in solution.
Determined size, refractive index, and mass of single particles.
Compatible with high-containment biological laboratories.
Abstract
Screening of unknown particles, including viruses and nanoparticles, is key in medicine, industry and pollutant determination. However, existing techniques require sample a priori knowledge or modification (e.g. fluorescence). Here we introduce RYtov MIcroscopy for Nanoparticles Identification (RYMINI), a noninvasive and non-destructive optical approach that is combining holographic labelfree 3D tracking and high-sensitivity quantitative phase imaging into a compact optical setup. Dedicated to the characterization of nano-objects in solution, it is compatible with highly demanding environments such as level-3 biological laboratories. Metrological characterization has been performed at the level of each single object on both absorbing and transparent particles as well as on infectious HIV-1, SARS-CoV-2 and extracellular vesicles in solution. We demonstrate the capability of RYMINI to…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
